Presentation: New approaches for vaccine adjuvants development in prophylactic vaccines

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Subscribe to VaccineNation Newsletter?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Dr Else Marie Agger, Head of Research, SSI joined us at the World Vaccine Congress Lyon 2012 to lead a discussion into new approaches for adjuvant development in prophylactic vaccines.

Why not download the full presentation and discover more about new approaches for vaccine adjuvants development in prophylactic vaccines. Dr Agger’s covered the following discussion points:

Overview of adjuvant development
Novel two component adjuvants for induction of cell-mediated immune responses
Case studies with a focus on preclinical development, manufacturing process and human phase I trials

Download the full presentation here >

Presentation: New approaches for vaccine adjuvants development in prophylactic vaccines

information we require

please check before submitting